Contact us for a free case consultation 866-281-8659

Living Safer Magazine

Check out the latest issue of D’Amore Law Group’s Living Safer magazine!

Categories

Archive for the ‘Product Liability’ Category

Jury awards $417 million in case linking Johnson’s Baby Powder to cancer
Wednesday, August 30th, 2017

A receptionist who developed ovarian cancer after using Johnson’s Baby Powder for decades was recently awarded $417 million in damages by a Los Angeles jury. This could be the largest award in a lawsuit that links ovarian cancer to talcum powder. Eva Echeverria is one of thousands of women who sued Johnson & Johnson over […]

First case against AbbVie Inc. in series of AndroGel lawsuits goes to trial
Friday, June 30th, 2017

Earlier this month, AbbVie Inc. faced its first test trial in over 4,000 cases filed against the company for overselling testosterone replacement drug AndroGel and for failing to warn of its potential side effects. AndroGel is a topical treatment for low testosterone. The first plaintiff, Jeffrey Konrad, suffered a heart attack in 2010 that he […]

Corporations win first trial against blood-thinner Xarelto
Thursday, May 11th, 2017

Patients complain that Xarelto, a blood-thinning drug developed to help reduce strokes is causing internal bleeding that has required hospitalization in some cases. Xarelto was jointly developed by Bayer and Johnson and Johnson. It is Bayer’s top-selling product, amassing $3.24 billion in sales last year. In the first product liability Xarelto case to go to trial, […]

Invanka Trump Scarves Recalled Due to ‘Burn Risk’
Friday, April 8th, 2016

Approximately 20,000 scarves manufactured in China under the Ivanka Trump Collection brand were recalled earlier this month due to their potential “burn risk”, according to a press release by the US Consumer Product Safety Commission. The CPSC warns that consumers should stop use of the scarves immediately, and return them to their place of purchase […]

Patients in California Being Treated for Macular Degeneration Blinded by Eye Injections of Avastin
Wednesday, September 7th, 2011

The media is reporting that five patients being treated at the Veterans Affairs Medical Center in Los Angeles, California, for wet age-related macular degeneration (AMD) have been blinded following eye injections of contaminated Avastin that had been repackaged into smaller doses.  The news comes following reports of serious eye infections suffered by patients in Florida and […]

Dangerous Ingredients in Dietary Supplements
Wednesday, August 31st, 2011

Increased risk of heart attack or stroke, kidney failure, liver damage, depression and addiction are just a few of the reported problems caused by tainted products sold openly as dietary supplements. Marketing drugs as supplements is illegal, and can pose very serious health risks.  There are two big problems inherent in the dietary supplement industry: […]

The Dangers of Cheap Cosmetic Contact Lenses
Monday, August 29th, 2011

Federal law mandates that all contact lenses, even those for cosmetic purposes such as to change the color of the wearer's eyes, can only be purchased with a valid prescription. However, many teenage girls have been purchasing illegal cosmetic contact lenses to change their eye color at local beauty stores. The results can be disastrous. […]

The Danger of Buying Stolen Blood Glucose Monitoring Products
Tuesday, July 5th, 2011

As the population ages, the incidence of diabetes is on the rise. More diabetics means greater demand for blood glucose monitoring products. It is in this vein that we report on the recent theft of a tractor-trailer shipment of Abbott Laboratories blood glucose monitoring products from a shipping carrier facility in Louisville, Kentucky. Stolen blood […]

Diabetes Drug Actos May Increase Risk of Cancer
Friday, June 17th, 2011

Actos a prescription drug of the class thiazolidinedione that is used to treat type 2 diabetes. This week, the FDA announced that patients taking Actos for more than a year may have an increased risk of bladder cancer. The FDA's announcement is based on its review of data from a planned five-year interim analysis of […]

FDA Recommends Reducing Dosage of Popular Cholesterol-Lowering Drug Simvastatin
Monday, June 13th, 2011

Simvastatin is a prescription drug used to control elevated cholesterol. Last week, the FDA recommended that doctor not start patients on an 80 mg dose of simvastatin – the highest approved dose of the drug — because of the risk of a condition known as myopathy, characterized by unexplained muscle weakness or pain. The FDA further […]